2023 Invited and Confirmed Panelists
- Rana Al-Hallaq, PhD, Executive Director, WWBD; Partner, Pfizer Ventures
- Peter Alff, PhD, Venture Partner, Orange Grove Bio
- Dawn Bell, PharmD, CEO, Board Director, Global Biopharma Leader
- Laurence Blumberg, MD, Biotechnology Executive
- Derek Brand, MBA, Executive Director, Strategic Partnerships, Columbia University
- Scott P. Bruder, MD, PhD, Founder & CEO, Bruder Consulting & Venture Group
- Eva Chmielnicki, PhD, Senior Director, Business Development, Bristol Myers Squibb
- Silvia Garcia Codony, MBA, MSc, Assistant Vice President, NY Ventures, Empire State Development
- Cat Donaldson, PhD, Principal & Head, Alexandria LaunchLabs at ACLS – NYC
- Christine Fischette, PhD, CEO, BioLinkUp LLC
- Michael Glynn, PhD, Partner, Fox Rothschild LLP
- Sherry Grisewood, CFA, Chief Investment Officer, Fox Hill Asset Management
- Jiaping Gu, PhD, Investment Director & Partner, Takeda Ventures
- Sam Hall, PhD, Life Sciences Venture Investor & Entrepreneur
- Dylan Harmon, MBA, Principal, H.I.G. Capital
- Frederick “Rick” Jones, MD, MBA, Partner, BioAdvance
- Kristen Kosofsky, Senior Managing Director, Hercules Capital
- Chris Liu, PhD, Senior Research Analyst, RTW Investments, LP
- Sanford J. Madigan, PhD, Managing Partner, Avalon BioVentures
- Jonathan Mandelbaum, PhD, Vice President, OrbiMed
- Nathan Meaux, Head of Northeast Biopharma, Diagnostics and Tools – Relationship Management, Silicon Valley Bank
- Saikat Nandi, PhD, MS, Founder and Managing Partner, GeneAllele Family Office, Former Portfolio Manager, AIG Investments
- Michael Norsen, MBA, Principal, Head, Alexandria LaunchLabs at Columbia – NYC
- Mariano Oppikofer, PhD, Research Project Leader, Emerging Science & Innovation, Centers for Therapeutic Innovation (CTI) Pfizer
- Sunil D. Pandit, PhD, ASCP(MB), Senior Director, Translational Medicine, Parexel
- John Prufeta, Founder, CEO & General Partner, Medical Excellence Capital, LLC
- Joseph Scaduto, MS, MBA, Co-Founder & CEO, CMTx Biotech Inc.
- Kevin Sharpe, PhD, Director, Oncology Business Development. Merck
- Nadim Shohdy, PhD, VP, Corporate Development, Hyku Bioscience; Former Entrepreneur-in-Residence, RA Capital
- Sabriya Stukes, PhD, Chief Scientific Officer, IndieBio
- Debi Watson, Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC
- Julie Wolf, PhD, Principal, 2048 Ventures
- Meg Wood, MPH, Managing Director, NYBC Ventures
- Peter Young, MBA, Venture Partner, Pappas Capital